Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development (Q37668036)

21 August 2017

1 reference

title

Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development (English)

1 reference

21 August 2017

Streptococcus pneumoniae

1 reference

1 reference

Richard Malley

1

1 reference

21 August 2017

5 January 2010

1 reference

Journal of Molecular Medicine

21 August 2017

1 reference

21 August 2017

88

1 reference

21 August 2017

2

1 reference

21 August 2017

135-142

1 reference

https://scigraph.springernature.com/pub.10.1007/s00109-009-0579-4

21 August 2017

0 references

cites work

Prevention of Pneumococcal Infection by Immunization with Capsular Polysaccharides of Streptococcus pneumoniae: Current Status of Polyvalent Vaccines

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00109-009-0579-4

Multiserotype protection of mice against pneumococcal colonization of the nasopharynx and middle ear by killed nonencapsulated cells given intranasally with a nontoxic adjuvant

21 January 2018

1 reference

12 December 2020

Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci

1 reference

12 December 2020

Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide

1 reference

12 December 2020

Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media

1 reference

12 December 2020

Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization

1 reference

12 December 2020

Sublingual immunization induces broad-based systemic and mucosal immune responses in mice

1 reference

12 December 2020

Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae

1 reference

12 December 2020

Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae

1 reference

12 December 2020

Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination

1 reference

12 December 2020

Low CD4 T cell immunity to pneumolysin is associated with nasopharyngeal carriage of pneumococci in children.

1 reference

12 December 2020

Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage

1 reference

12 December 2020

Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model

1 reference

12 December 2020

In vivo polysaccharide-specific IgG isotype responses to intact Streptococcus pneumoniae are T cell dependent and require CD40- and B7-ligand interactions

1 reference

12 December 2020

Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins

1 reference

12 December 2020

Interleukin-17A mediates acquired immunity to pneumococcal colonization

1 reference

12 December 2020

Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae

1 reference

12 December 2020

Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine

1 reference

12 December 2020

Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization

1 reference

12 December 2020

Decreased Serum Opsonic Activity against Streptococcus pneumoniae in Human Immunodeficiency Virus--Infected Ugandan Adults

1 reference

12 December 2020

Epidemiological evidence for serotype-independent acquired immunity to pneumococcal carriage

1 reference

12 December 2020

Antibody Responses to Nasopharyngeal Carriage ofStreptococcus pneumoniaein Adults: A Longitudinal Household Study

1 reference

12 December 2020

Serum antipneumococcal antibodies and pneumococcal colonization in adults with chronic obstructive pulmonary disease.

1 reference

12 December 2020

WHO meeting on maternal and neonatal pneumococcal immunization

1 reference

12 December 2020

Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection.

1 reference

12 December 2020

Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome

1 reference

12 December 2020

Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003

1 reference

12 December 2020

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

1 reference

12 December 2020

Interpreting results from trials of pneumococcal conjugate vaccines: a statistical test for detecting vaccine-induced increases in carriage of nonvaccine serotypes

1 reference

12 December 2020

Epidemiologic evidence for serotype-specific acquired immunity to pneumococcal carriage

1 reference

12 December 2020

Mucosal immunity and vaccines

1 reference

12 December 2020

Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants

1 reference

12 December 2020

Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae

1 reference

12 December 2020

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization

1 reference

12 December 2020

Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide

1 reference

12 December 2020

Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children

1 reference

12 December 2020

The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group

1 reference

12 December 2020

Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA

1 reference

12 December 2020

Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci

1 reference

12 December 2020

Impact of human immunodeficiency virus infection on Streptococcus pneumoniae colonization and seroepidemiology among Zambian women

1 reference

12 December 2020

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

1 reference

12 December 2020

Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice

1 reference

12 December 2020

Some aspects of the pneumococcal carrier state.

1 reference

12 December 2020

The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection

1 reference

12 December 2020

Cross-reactivity of human immunoglobulin G2 recognizing phosphorylcholine and evidence for protection against major bacterial pathogens of the human respiratory tract

1 reference

12 December 2020

Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease?

1 reference

12 December 2020

HIV-1 infection is associated with altered innate pulmonary immunity.

1 reference

12 December 2020

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

1 reference

12 December 2020

Protection against bacteremic pneumococcal infection by antibody to pneumolysin

1 reference

12 December 2020

Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae

1 reference

12 December 2020

The immune response to pneumococcal proteins during experimental human carriage

1 reference

12 December 2020

Dynamics of pneumococcal colonization in healthy Dutch children

1 reference

12 December 2020

Mass vaccination: solutions in the skin.

1 reference

12 December 2020

Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies

1 reference

12 December 2020

Continued impact of pneumococcal conjugate vaccine on carriage in young children.

1 reference

12 December 2020

Serotype-specific problems associated with pneumococcal conjugate vaccination

1 reference

12 December 2020

Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).

1 reference

12 December 2020

Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study

1 reference

12 December 2020

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

12 December 2020

10.1007/S00109-009-0579-4

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

20049411